Boya Bio-Pharmaceutical's major shareholder updates share pledge and release activity

Shenzhen CR Boya Bio-Pharmaceutical Group Co., Ltd. (Boya Bio-Pharmaceutical) announced that its major shareholder, High-Tech Holding Group Co., Ltd., released 450,000 unrestricted circulating shares, representing 0.09% of the company's total share capital, effective December 12, 2025. Concurrently, a subsidiary of High-Tech Holding Group pledged 950,000 unrestricted circulating shares, equivalent to 0.19% of Boya Bio-Pharmaceutical's total share capital, for financing purposes with Xiamen International Bank Co., Ltd., Zhuhai Branch.

Following these transactions, High-Tech Holding Group and its subsidiaries collectively hold 58,450,074 unrestricted circulating shares, accounting for 11.59% of Boya Bio-Pharmaceutical's total share capital. The total number of pledged shares held by High-Tech Holding Group and its subsidiary after these adjustments is 37,821,660 shares, representing 64.71% of their total holdings and 7.50% of the company's total share capital.

The company stated that the pledged and frozen shares held by High-Tech Holding Group do not pose a risk of forced liquidation or transfer, and the events do not impact Boya Bio-Pharmaceutical's operations, governance, or CR Pharma's voting rights.